Pi3k
Entity.
- Evidence
- 57 documents · 19 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 15 Mar 2026, last seen 21 Oct 2026
- Measured
- 2% of mentions say something specific about it; the rest only name it
- As of
- 22 Oct 2026
Where this comes from
- bioRxiv Cancer Biology · 2026-10-20 · A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancers (opens the source in a new tab)
- Fierce Biotech · 2026-10-13 · Merck KGaA spinout iOnctura touts PI3K delta inhibitor in metastatic eye cancer (opens the source in a new tab)
- Sci Adv · 2026-09-23 · RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. (opens the source in a new tab)